Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 164 | 2025 | 3252 | 13.050 |
Why?
|
Pulmonary Emphysema | 30 | 2024 | 689 | 4.190 |
Why?
|
alpha 1-Antitrypsin Deficiency | 12 | 2024 | 113 | 3.110 |
Why?
|
Forced Expiratory Volume | 40 | 2025 | 1831 | 2.650 |
Why?
|
Lung | 45 | 2024 | 10099 | 1.950 |
Why?
|
Idiopathic Pulmonary Fibrosis | 8 | 2024 | 521 | 1.940 |
Why?
|
Emphysema | 14 | 2024 | 236 | 1.830 |
Why?
|
Genetic Predisposition to Disease | 72 | 2024 | 18065 | 1.750 |
Why?
|
Smoking | 56 | 2024 | 9092 | 1.680 |
Why?
|
Genome-Wide Association Study | 53 | 2024 | 12795 | 1.610 |
Why?
|
alpha 1-Antitrypsin | 11 | 2024 | 169 | 1.540 |
Why?
|
Spirometry | 20 | 2024 | 929 | 1.300 |
Why?
|
Asthma | 21 | 2025 | 6291 | 1.260 |
Why?
|
Polymorphism, Single Nucleotide | 52 | 2024 | 16045 | 1.120 |
Why?
|
Polyadenylation | 3 | 2024 | 114 | 1.080 |
Why?
|
Quantitative Trait Loci | 13 | 2024 | 2131 | 1.070 |
Why?
|
Gene Expression Profiling | 15 | 2024 | 9538 | 0.950 |
Why?
|
Gene Regulatory Networks | 9 | 2024 | 1752 | 0.900 |
Why?
|
Genetic Linkage | 8 | 2014 | 2342 | 0.870 |
Why?
|
3' Untranslated Regions | 2 | 2024 | 515 | 0.830 |
Why?
|
Pulmonary Medicine | 2 | 2019 | 223 | 0.770 |
Why?
|
Sequence Analysis, RNA | 6 | 2022 | 2040 | 0.760 |
Why?
|
Respiration Disorders | 2 | 2022 | 364 | 0.750 |
Why?
|
Pharmacogenetics | 2 | 2019 | 683 | 0.730 |
Why?
|
Severity of Illness Index | 26 | 2024 | 15948 | 0.720 |
Why?
|
Phenotype | 38 | 2024 | 16726 | 0.710 |
Why?
|
Bronchodilator Agents | 10 | 2021 | 518 | 0.680 |
Why?
|
Vital Capacity | 14 | 2025 | 996 | 0.650 |
Why?
|
Pulmonary Eosinophilia | 1 | 2019 | 78 | 0.640 |
Why?
|
Gene Expression Regulation | 16 | 2024 | 11928 | 0.600 |
Why?
|
Genetic Loci | 7 | 2019 | 2629 | 0.600 |
Why?
|
Sputum | 2 | 2019 | 517 | 0.600 |
Why?
|
Sleep Medicine Specialty | 1 | 2019 | 72 | 0.600 |
Why?
|
Respiratory Function Tests | 18 | 2024 | 1695 | 0.590 |
Why?
|
Disease Progression | 20 | 2024 | 13671 | 0.580 |
Why?
|
Middle Aged | 126 | 2025 | 223492 | 0.570 |
Why?
|
Tomography, X-Ray Computed | 31 | 2024 | 20760 | 0.560 |
Why?
|
Gene Expression | 7 | 2021 | 7598 | 0.550 |
Why?
|
Epoxide Hydrolases | 6 | 2010 | 122 | 0.550 |
Why?
|
Humans | 202 | 2025 | 768166 | 0.550 |
Why?
|
Eosinophils | 2 | 2018 | 952 | 0.540 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 5 | 2021 | 110 | 0.540 |
Why?
|
Macrophages, Alveolar | 1 | 2019 | 415 | 0.540 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 617 | 0.530 |
Why?
|
Respiratory Mucosa | 2 | 2019 | 439 | 0.520 |
Why?
|
Aged | 102 | 2024 | 171504 | 0.520 |
Why?
|
Pulmonary Diffusing Capacity | 4 | 2023 | 93 | 0.510 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3671 | 0.500 |
Why?
|
Genotype | 23 | 2023 | 13045 | 0.500 |
Why?
|
Adrenal Cortex Hormones | 4 | 2021 | 1886 | 0.500 |
Why?
|
Pulmonary Surfactant-Associated Protein B | 5 | 2008 | 44 | 0.490 |
Why?
|
Bronchitis, Chronic | 4 | 2022 | 82 | 0.490 |
Why?
|
Male | 131 | 2025 | 364719 | 0.480 |
Why?
|
Computational Biology | 8 | 2024 | 3568 | 0.470 |
Why?
|
Societies, Medical | 2 | 2024 | 3968 | 0.470 |
Why?
|
Genetic Markers | 9 | 2022 | 2603 | 0.460 |
Why?
|
Glutathione S-Transferase pi | 3 | 2013 | 99 | 0.460 |
Why?
|
Female | 132 | 2025 | 397192 | 0.450 |
Why?
|
Incidental Findings | 1 | 2019 | 698 | 0.440 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2540 | 0.430 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4648 | 0.410 |
Why?
|
Hepatitis C | 1 | 2023 | 1595 | 0.410 |
Why?
|
Transforming Growth Factor beta1 | 4 | 2024 | 638 | 0.370 |
Why?
|
SOXD Transcription Factors | 1 | 2011 | 44 | 0.370 |
Why?
|
Proteomics | 8 | 2024 | 3912 | 0.340 |
Why?
|
Exercise Tolerance | 5 | 2023 | 846 | 0.330 |
Why?
|
Genetic Variation | 11 | 2024 | 6611 | 0.330 |
Why?
|
Cachexia | 3 | 2020 | 202 | 0.330 |
Why?
|
Oxygen | 2 | 2018 | 4270 | 0.330 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2010 | 313 | 0.320 |
Why?
|
Heterozygote | 6 | 2022 | 2798 | 0.320 |
Why?
|
Respiratory Mechanics | 1 | 2013 | 721 | 0.320 |
Why?
|
Case-Control Studies | 27 | 2024 | 22291 | 0.320 |
Why?
|
Aged, 80 and over | 36 | 2024 | 59629 | 0.300 |
Why?
|
Activin Receptors, Type I | 2 | 2019 | 134 | 0.300 |
Why?
|
Genome, Human | 5 | 2018 | 4446 | 0.300 |
Why?
|
Indians, Central American | 1 | 2007 | 19 | 0.290 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2011 | 418 | 0.290 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2009 | 304 | 0.280 |
Why?
|
Sepsis | 1 | 2021 | 2608 | 0.280 |
Why?
|
DNA Methylation | 5 | 2023 | 4428 | 0.280 |
Why?
|
beta-Defensins | 1 | 2006 | 60 | 0.270 |
Why?
|
Scavenger Receptors, Class A | 1 | 2006 | 52 | 0.270 |
Why?
|
Longitudinal Studies | 19 | 2024 | 14783 | 0.260 |
Why?
|
Muscarinic Antagonists | 2 | 2018 | 136 | 0.260 |
Why?
|
Genomics | 7 | 2024 | 5926 | 0.260 |
Why?
|
Critical Care | 1 | 2019 | 2715 | 0.260 |
Why?
|
Iron Regulatory Protein 2 | 3 | 2015 | 43 | 0.250 |
Why?
|
Cluster Analysis | 7 | 2023 | 2732 | 0.250 |
Why?
|
Genetic Testing | 1 | 2019 | 3591 | 0.250 |
Why?
|
Proteoglycans | 1 | 2009 | 809 | 0.250 |
Why?
|
Linkage Disequilibrium | 7 | 2017 | 1997 | 0.250 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2006 | 452 | 0.240 |
Why?
|
DNA Helicases | 1 | 2010 | 854 | 0.240 |
Why?
|
Membrane Glycoproteins | 5 | 2021 | 3711 | 0.240 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2024 | 81 | 0.230 |
Why?
|
Cohort Studies | 26 | 2024 | 41754 | 0.230 |
Why?
|
Fibroblasts | 4 | 2024 | 4176 | 0.230 |
Why?
|
Europe | 5 | 2024 | 3436 | 0.230 |
Why?
|
Quantitative Trait, Heritable | 1 | 2006 | 540 | 0.220 |
Why?
|
RNA | 3 | 2023 | 2720 | 0.220 |
Why?
|
Risk Factors | 34 | 2024 | 74944 | 0.220 |
Why?
|
Molecular Epidemiology | 3 | 2020 | 473 | 0.220 |
Why?
|
Costa Rica | 4 | 2025 | 186 | 0.220 |
Why?
|
Niacin | 1 | 2023 | 117 | 0.210 |
Why?
|
Respiratory Physiological Phenomena | 2 | 2023 | 192 | 0.200 |
Why?
|
Mucin-5B | 1 | 2023 | 148 | 0.200 |
Why?
|
Exons | 5 | 2023 | 2394 | 0.200 |
Why?
|
Interleukin-13 | 1 | 2024 | 390 | 0.200 |
Why?
|
Polymorphism, Genetic | 6 | 2013 | 4249 | 0.200 |
Why?
|
RNA Splice Sites | 1 | 2023 | 213 | 0.200 |
Why?
|
Carrier Proteins | 5 | 2021 | 4937 | 0.200 |
Why?
|
Thoracoscopy | 1 | 2003 | 186 | 0.200 |
Why?
|
Somatomedins | 1 | 2022 | 179 | 0.200 |
Why?
|
Genes, Overlapping | 1 | 2021 | 36 | 0.190 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 2 | 2012 | 49 | 0.190 |
Why?
|
Administration, Inhalation | 3 | 2021 | 1169 | 0.190 |
Why?
|
Models, Genetic | 4 | 2017 | 3447 | 0.190 |
Why?
|
HLA-A2 Antigen | 1 | 2021 | 207 | 0.180 |
Why?
|
Albuterol | 2 | 2014 | 211 | 0.180 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2010 | 1247 | 0.180 |
Why?
|
Desmoplakins | 1 | 2020 | 63 | 0.180 |
Why?
|
Serpin E2 | 4 | 2020 | 48 | 0.180 |
Why?
|
Status Asthmaticus | 1 | 2020 | 21 | 0.180 |
Why?
|
Risk Assessment | 10 | 2024 | 24315 | 0.180 |
Why?
|
Protective Agents | 1 | 2021 | 150 | 0.180 |
Why?
|
Genetic Association Studies | 4 | 2018 | 2744 | 0.180 |
Why?
|
Receptors, Nicotinic | 3 | 2015 | 494 | 0.170 |
Why?
|
Follow-Up Studies | 13 | 2021 | 39348 | 0.170 |
Why?
|
Pneumonectomy | 1 | 2007 | 1156 | 0.170 |
Why?
|
Algorithms | 8 | 2024 | 14164 | 0.170 |
Why?
|
Pleural Effusion | 1 | 2003 | 344 | 0.170 |
Why?
|
United States | 20 | 2024 | 73039 | 0.170 |
Why?
|
Databases, Genetic | 3 | 2019 | 1758 | 0.170 |
Why?
|
Models, Statistical | 3 | 2021 | 5107 | 0.170 |
Why?
|
Body Mass Index | 7 | 2019 | 13053 | 0.160 |
Why?
|
Chromosomes, Human, Pair 15 | 3 | 2015 | 361 | 0.160 |
Why?
|
Citrullus | 1 | 2018 | 4 | 0.160 |
Why?
|
Linear Models | 7 | 2020 | 5884 | 0.160 |
Why?
|
Adult | 36 | 2025 | 223646 | 0.160 |
Why?
|
Chromosome Mapping | 5 | 2018 | 4620 | 0.160 |
Why?
|
Hemolysis | 1 | 2021 | 417 | 0.160 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2019 | 71 | 0.160 |
Why?
|
RNA Splicing | 1 | 2023 | 905 | 0.160 |
Why?
|
Lung Neoplasms | 3 | 2019 | 13586 | 0.150 |
Why?
|
Comorbidity | 6 | 2016 | 10590 | 0.150 |
Why?
|
Interferons | 1 | 2022 | 720 | 0.150 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2018 | 30 | 0.150 |
Why?
|
Alternative Splicing | 2 | 2023 | 1105 | 0.150 |
Why?
|
Heme | 1 | 2020 | 316 | 0.150 |
Why?
|
Oligonucleotides | 1 | 2021 | 563 | 0.150 |
Why?
|
Adolescent Development | 1 | 2021 | 276 | 0.150 |
Why?
|
F-Box Proteins | 1 | 2019 | 199 | 0.140 |
Why?
|
Leukocyte Count | 2 | 2018 | 1609 | 0.140 |
Why?
|
Chromosomes, Human, Pair 4 | 5 | 2024 | 378 | 0.140 |
Why?
|
Plant Diseases | 1 | 2018 | 184 | 0.140 |
Why?
|
Sarcopenia | 1 | 2022 | 378 | 0.140 |
Why?
|
Immunoglobulin E | 2 | 2021 | 1506 | 0.140 |
Why?
|
Xenobiotics | 1 | 2017 | 71 | 0.140 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2021 | 329 | 0.140 |
Why?
|
Hypersensitivity, Immediate | 1 | 2020 | 349 | 0.140 |
Why?
|
Serine Proteinase Inhibitors | 2 | 2011 | 174 | 0.140 |
Why?
|
Prospective Studies | 15 | 2024 | 54926 | 0.140 |
Why?
|
Herpesvirus 4, Human | 1 | 2023 | 1082 | 0.140 |
Why?
|
MicroRNAs | 2 | 2025 | 3803 | 0.140 |
Why?
|
DNA | 2 | 2010 | 7214 | 0.140 |
Why?
|
Radiography, Thoracic | 2 | 2014 | 1321 | 0.140 |
Why?
|
Signal Transduction | 4 | 2024 | 23645 | 0.140 |
Why?
|
Age of Onset | 5 | 2017 | 3347 | 0.140 |
Why?
|
Enhancer Elements, Genetic | 2 | 2014 | 1367 | 0.130 |
Why?
|
Software | 3 | 2020 | 4478 | 0.130 |
Why?
|
Plant Proteins | 1 | 2018 | 376 | 0.130 |
Why?
|
rac GTP-Binding Proteins | 1 | 2017 | 163 | 0.130 |
Why?
|
HIV Infections | 1 | 2023 | 17569 | 0.130 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5889 | 0.130 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4786 | 0.130 |
Why?
|
Carbon Monoxide | 1 | 2019 | 560 | 0.130 |
Why?
|
C-Reactive Protein | 2 | 2012 | 3858 | 0.130 |
Why?
|
Hepacivirus | 1 | 2023 | 1344 | 0.130 |
Why?
|
Galactosylceramidase | 1 | 2015 | 23 | 0.120 |
Why?
|
Smoking Cessation | 3 | 2020 | 2085 | 0.120 |
Why?
|
Surgery, Computer-Assisted | 1 | 2003 | 1003 | 0.120 |
Why?
|
Cadherins | 2 | 2017 | 905 | 0.120 |
Why?
|
Axonemal Dyneins | 1 | 2014 | 25 | 0.120 |
Why?
|
Metabolomics | 2 | 2021 | 1674 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1793 | 0.120 |
Why?
|
Adrenergic beta-Agonists | 1 | 2016 | 347 | 0.120 |
Why?
|
Pneumonia | 2 | 2017 | 2163 | 0.120 |
Why?
|
RNA, Viral | 1 | 2023 | 2872 | 0.110 |
Why?
|
Dyspnea | 4 | 2023 | 1352 | 0.110 |
Why?
|
RNA, Untranslated | 1 | 2017 | 455 | 0.110 |
Why?
|
Dermatitis, Atopic | 1 | 2021 | 737 | 0.110 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15662 | 0.110 |
Why?
|
Glutathione Transferase | 2 | 2013 | 564 | 0.110 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2010 | 1117 | 0.110 |
Why?
|
Alleles | 7 | 2017 | 6894 | 0.110 |
Why?
|
Quality of Life | 11 | 2023 | 13490 | 0.110 |
Why?
|
Metformin | 1 | 2021 | 909 | 0.110 |
Why?
|
Nerve Tissue Proteins | 4 | 2021 | 4413 | 0.110 |
Why?
|
Protease Nexins | 2 | 2010 | 39 | 0.110 |
Why?
|
Pectoralis Muscles | 1 | 2014 | 86 | 0.110 |
Why?
|
Lymphocytes | 1 | 2021 | 2614 | 0.110 |
Why?
|
Rest | 3 | 2016 | 948 | 0.110 |
Why?
|
Pedigree | 4 | 2009 | 4539 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 940 | 0.110 |
Why?
|
Chemokines | 1 | 2017 | 963 | 0.110 |
Why?
|
Radiology | 1 | 2007 | 2104 | 0.100 |
Why?
|
Osteoporosis | 1 | 2022 | 1605 | 0.100 |
Why?
|
Cystic Fibrosis | 1 | 2022 | 1294 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1469 | 0.100 |
Why?
|
Gene Frequency | 4 | 2021 | 3623 | 0.100 |
Why?
|
Multivariate Analysis | 8 | 2020 | 12077 | 0.100 |
Why?
|
Uteroglobin | 1 | 2012 | 56 | 0.100 |
Why?
|
RNA-Binding Proteins | 2 | 2020 | 1890 | 0.100 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 801 | 0.100 |
Why?
|
Chromosomes, Human | 1 | 2014 | 438 | 0.100 |
Why?
|
Lung Volume Measurements | 1 | 2013 | 381 | 0.100 |
Why?
|
Cytokines | 2 | 2017 | 7453 | 0.100 |
Why?
|
North America | 3 | 2015 | 1289 | 0.100 |
Why?
|
Pulmonary Artery | 2 | 2024 | 1946 | 0.100 |
Why?
|
Predictive Value of Tests | 5 | 2022 | 15454 | 0.090 |
Why?
|
Prognosis | 8 | 2024 | 30010 | 0.090 |
Why?
|
Transcription Factors | 3 | 2022 | 12168 | 0.090 |
Why?
|
Infant, Premature | 1 | 2021 | 2124 | 0.090 |
Why?
|
Disease Management | 2 | 2020 | 2536 | 0.090 |
Why?
|
Lod Score | 2 | 2009 | 600 | 0.090 |
Why?
|
Pneumothorax | 1 | 2014 | 393 | 0.090 |
Why?
|
Blood Proteins | 1 | 2016 | 1191 | 0.090 |
Why?
|
Superoxide Dismutase | 2 | 2010 | 596 | 0.090 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2011 | 350 | 0.090 |
Why?
|
Vitamin D Deficiency | 1 | 2020 | 1388 | 0.090 |
Why?
|
Disease Models, Animal | 4 | 2023 | 18349 | 0.090 |
Why?
|
Pulmonary Alveoli | 1 | 2013 | 665 | 0.090 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2009 | 44 | 0.090 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9615 | 0.090 |
Why?
|
Receptors, Cell Surface | 2 | 2010 | 2819 | 0.090 |
Why?
|
DNA Mutational Analysis | 2 | 2018 | 4120 | 0.090 |
Why?
|
Norway | 4 | 2014 | 501 | 0.080 |
Why?
|
Logistic Models | 7 | 2019 | 13290 | 0.080 |
Why?
|
Child Development | 1 | 2021 | 2330 | 0.080 |
Why?
|
Cross-Sectional Studies | 9 | 2020 | 26379 | 0.080 |
Why?
|
Survival Analysis | 5 | 2022 | 10101 | 0.080 |
Why?
|
Consensus | 1 | 2019 | 3212 | 0.080 |
Why?
|
Child | 14 | 2025 | 80917 | 0.080 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2017 | 957 | 0.080 |
Why?
|
Respiratory Insufficiency | 1 | 2017 | 1240 | 0.080 |
Why?
|
Respiratory Tract Diseases | 1 | 2014 | 744 | 0.080 |
Why?
|
Premature Birth | 1 | 2021 | 1829 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2018 | 2167 | 0.080 |
Why?
|
Sensitivity and Specificity | 4 | 2017 | 14729 | 0.080 |
Why?
|
Penetrance | 2 | 2023 | 385 | 0.080 |
Why?
|
Respiratory System | 2 | 2015 | 564 | 0.080 |
Why?
|
Inflammation | 4 | 2023 | 10873 | 0.080 |
Why?
|
Odds Ratio | 5 | 2022 | 9669 | 0.080 |
Why?
|
Radiographic Image Enhancement | 1 | 2013 | 877 | 0.080 |
Why?
|
Mice | 7 | 2023 | 82029 | 0.080 |
Why?
|
Blood Vessels | 1 | 2013 | 1110 | 0.070 |
Why?
|
Microsatellite Repeats | 2 | 2006 | 785 | 0.070 |
Why?
|
Lead | 1 | 2013 | 882 | 0.070 |
Why?
|
Tobacco Smoke Pollution | 2 | 2011 | 828 | 0.070 |
Why?
|
Gene Order | 1 | 2007 | 166 | 0.070 |
Why?
|
CpG Islands | 2 | 2023 | 1208 | 0.070 |
Why?
|
Elastin | 1 | 2008 | 299 | 0.070 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2007 | 88 | 0.070 |
Why?
|
Prevalence | 4 | 2020 | 15869 | 0.070 |
Why?
|
tau Proteins | 1 | 2018 | 2144 | 0.070 |
Why?
|
Animals | 8 | 2023 | 169246 | 0.070 |
Why?
|
Protein Isoforms | 2 | 2021 | 1715 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2017 | 20227 | 0.070 |
Why?
|
Genetic Heterogeneity | 1 | 2010 | 736 | 0.070 |
Why?
|
Latent TGF-beta Binding Proteins | 1 | 2006 | 45 | 0.070 |
Why?
|
Age Factors | 3 | 2021 | 18412 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2017 | 3139 | 0.060 |
Why?
|
Epithelial Cells | 2 | 2020 | 3703 | 0.060 |
Why?
|
ADAM Proteins | 1 | 2007 | 242 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2017 | 3329 | 0.060 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2024 | 30 | 0.060 |
Why?
|
Boston | 5 | 2021 | 9374 | 0.060 |
Why?
|
Airway Obstruction | 1 | 2010 | 672 | 0.060 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2006 | 432 | 0.060 |
Why?
|
Tobacco Use Disorder | 1 | 2011 | 708 | 0.060 |
Why?
|
Multifactorial Inheritance | 2 | 2024 | 1422 | 0.060 |
Why?
|
Epoxy Compounds | 1 | 2005 | 137 | 0.060 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2005 | 165 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2021 | 81762 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2022 | 3800 | 0.060 |
Why?
|
Chronic Disease | 1 | 2019 | 9384 | 0.060 |
Why?
|
Treatment Outcome | 7 | 2021 | 65371 | 0.060 |
Why?
|
Radiography | 2 | 2014 | 6983 | 0.060 |
Why?
|
Mixed Function Oxygenases | 1 | 2005 | 265 | 0.060 |
Why?
|
Proteins | 1 | 2018 | 6009 | 0.060 |
Why?
|
Family Health | 2 | 2006 | 1255 | 0.050 |
Why?
|
Siblings | 1 | 2007 | 828 | 0.050 |
Why?
|
Morbidity | 2 | 2022 | 1755 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3239 | 0.050 |
Why?
|
Drug Therapy, Combination | 3 | 2021 | 6316 | 0.050 |
Why?
|
Thoracoscopes | 1 | 2002 | 3 | 0.050 |
Why?
|
Adiponectin | 2 | 2019 | 1117 | 0.050 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2005 | 781 | 0.050 |
Why?
|
Myofibroblasts | 1 | 2024 | 230 | 0.050 |
Why?
|
Epigenomics | 2 | 2019 | 960 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22379 | 0.050 |
Why?
|
Oximetry | 2 | 2016 | 462 | 0.050 |
Why?
|
Hypertension, Pulmonary | 2 | 2015 | 1605 | 0.050 |
Why?
|
Drug Repositioning | 1 | 2024 | 246 | 0.050 |
Why?
|
Proteinase Inhibitory Proteins, Secretory | 1 | 2021 | 49 | 0.050 |
Why?
|
HLA Antigens | 1 | 2007 | 1334 | 0.050 |
Why?
|
Cloning, Molecular | 1 | 2007 | 4168 | 0.050 |
Why?
|
GTPase-Activating Proteins | 2 | 2015 | 467 | 0.050 |
Why?
|
Adolescent | 7 | 2025 | 89169 | 0.050 |
Why?
|
Carcinoma, Bronchogenic | 1 | 2001 | 86 | 0.050 |
Why?
|
Promoter Regions, Genetic | 3 | 2011 | 5797 | 0.050 |
Why?
|
Punctures | 1 | 2003 | 372 | 0.050 |
Why?
|
Pleural Diseases | 1 | 2002 | 138 | 0.050 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 561 | 0.050 |
Why?
|
Codon, Terminator | 1 | 2021 | 125 | 0.050 |
Why?
|
Niacinamide | 1 | 2023 | 418 | 0.050 |
Why?
|
Myosins | 1 | 2022 | 408 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2007 | 1361 | 0.050 |
Why?
|
Interleukin-4 | 1 | 2024 | 1156 | 0.040 |
Why?
|
Observer Variation | 1 | 2007 | 2622 | 0.040 |
Why?
|
Surgical Instruments | 1 | 2003 | 381 | 0.040 |
Why?
|
Incidence | 5 | 2024 | 21538 | 0.040 |
Why?
|
Genes, Switch | 1 | 2020 | 48 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 325 | 0.040 |
Why?
|
Arylsulfotransferase | 1 | 2019 | 27 | 0.040 |
Why?
|
rab4 GTP-Binding Proteins | 1 | 2019 | 7 | 0.040 |
Why?
|
Hand Strength | 1 | 2022 | 466 | 0.040 |
Why?
|
Colletotrichum | 1 | 2018 | 1 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2013 | 3980 | 0.040 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2022 | 453 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2012 | 4352 | 0.040 |
Why?
|
Weight Loss | 2 | 2021 | 2721 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 8054 | 0.040 |
Why?
|
Bronchi | 2 | 2013 | 850 | 0.040 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2019 | 246 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2006 | 1996 | 0.040 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2023 | 845 | 0.040 |
Why?
|
Muscles | 1 | 2022 | 1582 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2019 | 740 | 0.040 |
Why?
|
Receptors, Leptin | 1 | 2018 | 352 | 0.030 |
Why?
|
Family | 3 | 2017 | 3209 | 0.030 |
Why?
|
Cough | 2 | 2013 | 598 | 0.030 |
Why?
|
C-Peptide | 1 | 2018 | 443 | 0.030 |
Why?
|
Body Composition | 2 | 2017 | 2462 | 0.030 |
Why?
|
Sarcoglycans | 1 | 2015 | 57 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 663 | 0.030 |
Why?
|
Sample Size | 1 | 2019 | 846 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2892 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2023 | 12800 | 0.030 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2015 | 57 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2017 | 353 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2018 | 1162 | 0.030 |
Why?
|
New Zealand | 1 | 2015 | 360 | 0.030 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2015 | 144 | 0.030 |
Why?
|
Bronchitis | 1 | 2015 | 194 | 0.030 |
Why?
|
Young Adult | 5 | 2021 | 60066 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2568 | 0.030 |
Why?
|
Hospitalization | 1 | 2014 | 10840 | 0.030 |
Why?
|
Hepatocytes | 1 | 2021 | 1247 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12252 | 0.030 |
Why?
|
Total Lung Capacity | 1 | 2014 | 148 | 0.030 |
Why?
|
Massachusetts | 1 | 2007 | 8890 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1088 | 0.030 |
Why?
|
Mutation | 3 | 2023 | 30238 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15597 | 0.030 |
Why?
|
ABO Blood-Group System | 1 | 2016 | 381 | 0.030 |
Why?
|
Serpins | 1 | 2015 | 246 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3628 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7454 | 0.030 |
Why?
|
Time Factors | 3 | 2024 | 40218 | 0.030 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2014 | 411 | 0.030 |
Why?
|
Computer Simulation | 2 | 2017 | 6283 | 0.030 |
Why?
|
Reference Standards | 1 | 2017 | 1014 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2359 | 0.030 |
Why?
|
Electric Impedance | 1 | 2017 | 794 | 0.030 |
Why?
|
Mental Status Schedule | 1 | 2013 | 315 | 0.030 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2013 | 144 | 0.030 |
Why?
|
Down-Regulation | 1 | 2020 | 2937 | 0.030 |
Why?
|
Regeneration | 1 | 2021 | 1524 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12543 | 0.030 |
Why?
|
Heart Failure | 1 | 2016 | 11879 | 0.020 |
Why?
|
Sp3 Transcription Factor | 1 | 2011 | 30 | 0.020 |
Why?
|
Metabolome | 1 | 2019 | 1009 | 0.020 |
Why?
|
Bronchospirometry | 1 | 2011 | 10 | 0.020 |
Why?
|
Internationality | 1 | 2017 | 1008 | 0.020 |
Why?
|
Demography | 1 | 2017 | 1641 | 0.020 |
Why?
|
Tomography, Spiral Computed | 1 | 2013 | 273 | 0.020 |
Why?
|
Gestational Age | 1 | 2021 | 3621 | 0.020 |
Why?
|
Lung Transplantation | 1 | 2001 | 1309 | 0.020 |
Why?
|
Poland | 1 | 2012 | 197 | 0.020 |
Why?
|
Valine | 1 | 2013 | 410 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2021 | 19015 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2011 | 294 | 0.020 |
Why?
|
Sex Factors | 2 | 2016 | 10632 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1815 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1363 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2013 | 527 | 0.020 |
Why?
|
Leptin | 1 | 2018 | 1599 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2012 | 704 | 0.020 |
Why?
|
Cell Cycle | 1 | 2017 | 2932 | 0.020 |
Why?
|
Bone Density | 1 | 2022 | 3573 | 0.020 |
Why?
|
Fibrinogen | 1 | 2012 | 891 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2019 | 2709 | 0.020 |
Why?
|
Regression Analysis | 2 | 2009 | 6340 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2011 | 858 | 0.020 |
Why?
|
Online Systems | 1 | 2009 | 182 | 0.020 |
Why?
|
Extracellular Matrix Proteins | 1 | 2013 | 832 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2001 | 4206 | 0.020 |
Why?
|
Health Services | 1 | 2013 | 755 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1606 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42669 | 0.020 |
Why?
|
Gastroesophageal Reflux | 1 | 2016 | 836 | 0.020 |
Why?
|
Monocytes | 1 | 2017 | 2605 | 0.020 |
Why?
|
Angiography | 1 | 2013 | 1597 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5315 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2911 | 0.020 |
Why?
|
Hypercapnia | 1 | 2008 | 259 | 0.020 |
Why?
|
Walking | 1 | 2014 | 1201 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3773 | 0.020 |
Why?
|
Bronchoconstrictor Agents | 1 | 2006 | 77 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5799 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3833 | 0.020 |
Why?
|
Methacholine Chloride | 1 | 2006 | 220 | 0.020 |
Why?
|
Vitamin D | 1 | 2020 | 3311 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4978 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2013 | 1232 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14488 | 0.020 |
Why?
|
Reference Values | 1 | 2013 | 4938 | 0.020 |
Why?
|
Liver | 1 | 2021 | 7577 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 8080 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3533 | 0.020 |
Why?
|
Haplotypes | 1 | 2011 | 2722 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2810 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8375 | 0.010 |
Why?
|
Neutrophils | 1 | 2017 | 3786 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1737 | 0.010 |
Why?
|
Genetics, Population | 1 | 2009 | 944 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3436 | 0.010 |
Why?
|
International Cooperation | 1 | 2011 | 1436 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5027 | 0.010 |
Why?
|
Insulin | 1 | 2018 | 6607 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10266 | 0.010 |
Why?
|
Blood Glucose | 1 | 2018 | 6430 | 0.010 |
Why?
|
Acute Disease | 1 | 2014 | 7243 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4146 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3428 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12840 | 0.010 |
Why?
|
Occupational Exposure | 1 | 2013 | 1807 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2001 | 5432 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2012 | 3228 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 17140 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6229 | 0.010 |
Why?
|
Models, Biological | 1 | 2017 | 9495 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26422 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2007 | 1758 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2005 | 2923 | 0.010 |
Why?
|
Veterans | 1 | 2013 | 2669 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 9015 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2013 | 10474 | 0.010 |
Why?
|
Biomedical Research | 1 | 2011 | 3463 | 0.010 |
Why?
|
Equipment Design | 1 | 2002 | 3522 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21206 | 0.010 |
Why?
|
Aging | 1 | 2010 | 8744 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2001 | 11244 | 0.000 |
Why?
|